HepG2 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF1257
Target Cell Organism: Human
Target Cell Alternative Name: Hep G2
Target Cell Name: HepG2
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide HepG2-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HepG2
Target Cell Organism
Human
Target Cell Background
Hep G2 is an immortal cell line which was derived in 1975 from the liver tissue of a 15-year-old Caucasian male from Argentina with a well-differentiated hepatocellular carcinoma. These cells are epithelial in morphology, have a modal chromosome number of 55, and are not tumorigenic in nude mice.
Target Cell Alternative Name
Hep G2
Related Diseases
Hepatocellular Carcinoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
HepG2-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry